Wall Street analysts expect Gilead Sciences (GILD) to post quarterly earnings of $1.95 per share in its upcoming report, which indicates a year-over-year decline of 3$6.95 billion, down 0.1% from the year-ago quarter.The consensus EPS estimate for the quarter has been revised 1.1% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's e ...